Bart de Goeij

Bart de Goeij is a seasoned professional in the biotechnology sector, currently serving as the Director and Product Discovery Lead at Genmab since January 2007, where the focus is on developing fully human monoclonal antibodies for cancer treatment. Prior to this role, Bart worked as a microbiology analyst at the Academic Medical Center from January 2003 to September 2004, specializing in testing patient samples for bacterial infections and contributing to the development of PCR assays. Academically, Bart holds a Master's degree in Medical Biology and Immunology from the University of Amsterdam and a Bachelor's degree in Biology and Medical Laboratory Research from HU University of Applied Sciences Utrecht.